Claret Capital Partners
Claret Capital Partners is a specialist European growth-debt manager financing technology, life sciences, climate, and other innovative companies.
- Venture debt and growth-credit investment firm
- Venture Debt & Growth Credit
- Tier II
Overview
Claret Capital Partners is a specialist European growth-debt manager financing technology, life sciences, climate, and other innovative companies. It provides flexible facilities for expansion, acquisitions, commercialization, working capital, and runway extension across multiple European jurisdictions.
Claret combines regional investment teams with a consistent institutional strategy and has remained active through changes in venture valuations and funding conditions. Its borrower base includes companies with institutional sponsorship, meaningful revenue, valuable technology, or clearly defined development milestones. Within The Economy Wiki, the institution is connected to the Venture Debt & Growth Credit market category.
Firm facts
| Institution | Claret Capital Partners |
| Type | Venture debt and growth-credit investment firm |
| Headquarters | London, United Kingdom |
| Founded | 2013 |
| Primary ranking focus | Venture Debt & Growth Credit |
| Highest 2026 tier | Tier II |
Activities and credit capabilities
Claret Capital Partners operates within non-dilutive growth finance for venture-backed and scaling companies. Its activities are assessed through the category-specific capabilities summarized below.
Venture debt
Loans designed for venture-backed companies between equity-financing rounds.
Growth credit
Flexible debt for commercially established businesses funding expansion.
Founder financing
Capital structured to extend runway while limiting immediate equity dilution.
Strategy and transaction coverage
Strategy and asset coverage
Technology; software; life sciences; fintech; climate; consumer and other growth sectors
Financing and transaction contexts
Term loans; revolving facilities; recurring-revenue loans; equipment finance; acquisition and runway capital
Market position
Claret fits Tier II because it is one of Europe’s strongest independent growth-debt franchises. Its specialist focus, pan-European reach, and continued fundraising give it authority beyond any single national ecosystem.
Claret Capital Partners is assessed within the Venture Debt & Growth Credit framework. For wider market context, see Growth Equity vs Venture Capital and Buyouts: Key Differences.
Competitive context
Claret Capital Partners is recognized Tier II in Top 30 Venture Debt & Growth Credit 2026. The rankings compare institutions by market relevance, origination or operating capability, underwriting or platform depth, institutional credibility and current activity. Comparable links support navigation and do not imply that every institution competes for every financing or mandate.
Leadership and governance
Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through Claret Capital Partners’s official website.
| Leadership area | Current source |
|---|---|
| Investment and operating leadership | Current team and governance information |
Corporate and public information
This profile refers to Claret Capital Partners as the public-facing organization. Individual funds, management companies, advisers, lending entities and regulated affiliates may use separate legal names across jurisdictions.
Corporate and disclosure information
| Organization | Claret Capital Partners |
| Headquarters | London, United Kingdom |
| Public website | www.claret-capital.com |
| Profile basis | Public institutional information and Capital Ranking editorial research |
Ranking recognition
Related Economy analysis
Selected Economy Markets articles provide context for the lending, financing, diligence and private-market themes relevant to this institution:
- Growth Equity vs Venture Capital and Buyouts: Key Differences
- Private Credit’s Trillion-Dollar Growth Meets Its AI Debt Test
- Technology Private Equity: Scale, Due Diligence and the Small-Cap Advantage